Condensed Interim Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Operating expenses
Research and development	$ 270	$ 138	$ 635	$ 497
General and administrative	989	155	1,829	534
Total operating expenses	1,259	293	2,464	1,031
Loss from operations	(1,259)	(293)	(2,464)	(1,031)
Other income (expense)	6	(45)	(222)	(271)
Interest expense, net	15	21	195	43
Change in fair value of Forward Purchase Agreement	4,026		4,026
Total other expense (income)	4,047	(24)	3,999	(228)
Income (loss) before income taxes	(5,306)	(269)	(6,463)	(803)
Income tax expense
Net income (loss)	$ (5,306)	$ (269)	$ (6,463)	$ (803)
Basic weighted average Common shares outstanding (in Shares)	11,698,789	6,306,496	8,075,238	6,142,893
Basic net income (loss) per share, Common shares (in Dollars per share)	$ (0.45)	$ (0.04)	$ (0.8)	$ (0.13)